Detalhe da pesquisa
1.
Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
Catheter Cardiovasc Interv
; 98(4): 713-720, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33118696
2.
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
N Engl J Med
; 376(24): 2319-2328, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402237
3.
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.
Catheter Cardiovasc Interv
; 95(1): 89-96, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30968559
4.
ABSORB IV: will the low rate of scaffold thrombosis persist?
Lancet
; 393(10189): 2392, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31204677
5.
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial.
EuroIntervention
; 17(16): 1340-1347, 2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34483094
6.
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial.
Int J Cardiol
; 300: 93-98, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511193
7.
The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy.
Int J Cardiovasc Imaging
; 36(4): 565-575, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898006
8.
The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial.
Int J Cardiovasc Imaging
; 35(7): 1189-1198, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30911857
9.
Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?
Expert Rev Med Devices
; 14(5): 325-334, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402204
10.
Predictors of Intramyocardial Hemorrhage After Reperfused ST-Segment Elevation Myocardial Infarction.
J Am Heart Assoc
; 6(8)2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28862937
11.
Bioresorbable scaffolds for the treatment of acute coronary syndrome. A possible niche indication or not?
Cardiovasc Revasc Med
; 20(3): 261, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30904136
12.
1-Year Clinical Performance of COMBO Stent Versus Xience Stent in All-Comers Patients With Coronary Artery Disease.
JACC Cardiovasc Interv
; 11(1): 102-103, 2018 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301642